The findings from a study by Duke Cancer Institute researchers highlight the importance of considering medical costs as women face breast cancer treatment decisions.
“Overwhelmingly, women cared about the cost of their breast cancer care and almost half reported considering costs when making treatment decisions,” said Rachel Greenup, MD, who is presenting the findings Sept. 29 at the ASCO Quality Care Symposium in Phoenix. “Despite this, 79 percent reported never discussing costs with their medical team.”
The vast majority of women — eight out of 10 — said they preferred knowing the costs of treatment prior to embarking on cancer care. And 40 percent preferred that doctors consider costs when making treatment recommendations.
“Doctors and patients should be open to discussing the financial implications of treatment,” Greenup said.
In their study, the Duke team surveyed more than 750 women after breast cancer from the Army of Women and Sisters Network, national organizations of women after breast cancer. All were women with a median age of about 50. Most had either private health insurance or Medicare, and had annual household income of more than $74,000.
Even within this group — financially better off than many cancer patients — nearly 16 percent reported significant to catastrophic financial burden.
Median reported out-of-pocket costs were $3,500, although 5 percent of women faced out-of-pocket costs over $30,000.
“Cost transparency could improve the quality of treatment decisions patients make and has the potential to reduce the risk of financial harm,” Greenup said.